NVO has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Novo Nordisk A/S's credit losses provision for the three months ended in Mar. 2014 was $0 Mil. Its credit losses provision for the trailing twelve months (TTM) ended in Mar. 2014 was $0 Mil.
For each period of operations, banks may reserve a portion of their income to cover the possible non-performing loans. The amount of the Credit Losses Provision is dependent on the management's estimate of the load quality they have. The higher Credit Losses Provision is, the lower banks' reported income in. This does not affect banks' cash flow statement.
Novo Nordisk A/S Credit Losses Provision for the trailing twelve months (TTM) ended in Mar. 2014 was 0 (Jun. 2013 ) + 0 (Sep. 2013 ) + 0 (Dec. 2013 ) + 0 (Mar. 2014 ) = $0 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Novo Nordisk A/S Annual Data
Novo Nordisk A/S Quarterly Data